This is the first injectable product approval from our General Sterile Facility (F-3) which was inspected in August, 2022.
Esiloc was launched at the biggest doctor engagement webinar involving more than 12,000 doctors across the country
Agreement strengthens Evonik’s track record as leading contract development and manufacturing organization (CDMO)
The Allurion Program is suited for people who are unable to achieve their weight-loss goals by dieting alone or for those who do not want to, or cannot, undergo invasive surgery or endoscopy
Man lost 54 Kgs in 6 months with MGB procedure
The safety profile of KEYTRUDA plus LENVIMA was consistent with previously reported data on the combination.
Supports development and commercialization of complex oral drugs using sensitive molecules, including biologicals
The abstract is about the cohort A, stage I of the ongoing global phase ? trial that evaluating the safety and efficacy of Catumaxomab in advanced GC patients with peritoneal metastasis
HK inno.N Corporation will be responsible for the manufacture and supply of Tegoprazan, while Dr. Reddy's will handle local clinical development, registration, marketing and sales
Enhertu has now been granted five Breakthrough Therapy Designations, including three in breast cancer and one in both lung and gastric cancers
Subscribe To Our Newsletter & Stay Updated
